Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-03

FDA Approved: LANSOPRAZOLE — Supplemental Application (Lifestar Pharma LLC.)

View source ↗

Summary

FDA approves a supplemental application to allow Lifestar Pharma LLC to market a generic version of lansoprazole.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole (Lansoprazole)

Snippet

SUPPL AP for LANSOPRAZOLE (LANSOPRAZOLE)